Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R21DK139543-02
Development of selective degradation strategies towards mutant transcription factors
Recipient
National Institute of Diabetes and Digestive and Kidney Diseases
Award Amount
$211,250.00
Ceiling
$211,250.00
Awarded
August 07, 2025
Identifier
5R21DK139543-02
Research grant awarded by NIH/NIDDK to develop selective degradation strategies targeting mutant transcription factors, focusing on a mutation in the KLF1 gene associated with congenital dyserythropoietic anemia.
Description
This is a research grant opportunity for developing strategies to degrade mutant transcription factors, with a focus on a specific mutation in the KLF1 gene related to congenital dyserythropoietic anemia. The project is funded by NIH/NIDDK and involves in vitro and in vivo studies.